Stop marginalising men with breast cancer

by Kerry Quincey,The ConversationCredit: AI-generated imageBreast cancer is the most common cancer in theUKand the leading cancerin women worldwide. Approximately 150 cases are

Updated on: December 18,2023 12

Stop marginalising men with breast cancer

by Kerry Quincey,The ConversationCredit: AI-generated imageBreast cancer is the most common cancer in theUKand the leading cancerin women worldwide. Approximately 150 cases are

Updated on:December 18,2023 12

Non-hormonal therapy reduces hot flashes and night sweats in women who have been diagnosed with breast cancer

by Cheryl Critchley,Monash UniversityCredit: Pixabay/CC0 Public DomainA Monash University-led trial of a new drug known as Q-122 therapy significantly reduced the number and severity of hot flas

Updated on: December 22,2023 10

Non-hormonal therapy reduces hot flashes and night sweats in women who have been diagnosed with breast cancer

by Cheryl Critchley,Monash UniversityCredit: Pixabay/CC0 Public DomainA Monash University-led trial of a new drug known as Q-122 therapy significantly reduced the number and severity of hot flas

Updated on:December 22,2023 10

Obesity is a risk factor for cardiotoxicity in chemotherapy-treated patients with breast cancer

byPublic Library of ScienceObesity is associated with a three-fold increased risk of cardiotoxicity in chemotherapy-treated patients with early-stage breast cancer, regardless of other predictor

Updated on: December 22,2023 17

Obesity is a risk factor for cardiotoxicity in chemotherapy-treated patients with breast cancer

byPublic Library of ScienceObesity is associated with a three-fold increased risk of cardiotoxicity in chemotherapy-treated patients with early-stage breast cancer, regardless of other predictor

Updated on:December 22,2023 17

Olaparib maintenance extends PFS by estimated three years in advanced ovarian cancer

byEuropean Society for Medical OncologyTwo-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to a substantial, unprecedented improvement in pro

Updated on: December 18,2023 13

Olaparib maintenance extends PFS by estimated three years in advanced ovarian cancer

byEuropean Society for Medical OncologyTwo-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to a substantial, unprecedented improvement in pro

Updated on:December 18,2023 13

Marker found for condition that causes numerous tumors

by Cathy Frisinger,UT Southwestern Medical CenterCutaneous neurofibromas cover the back of a patient. Credit: UTSWUT Southwestern researchers have made a major advance in uncovering the biology

Updated on: December 18,2023 16

Marker found for condition that causes numerous tumors

by Cathy Frisinger,UT Southwestern Medical CenterCutaneous neurofibromas cover the back of a patient. Credit: UTSWUT Southwestern researchers have made a major advance in uncovering the biology

Updated on:December 18,2023 16

Antioxidant use during chemotherapy risky for breast cancer patients

by SWOGCredit: CC0 Public DomainBreast cancer patients who take the dietary supplements known as antioxidants, as well as iron, vitamin B12, and omega-3 fatty acids, during chemotherapy may be at incr

Updated on: December 23,2023 24

Antioxidant use during chemotherapy risky for breast cancer patients

by SWOGCredit: CC0 Public DomainBreast cancer patients who take the dietary supplements known as antioxidants, as well as iron, vitamin B12, and omega-3 fatty acids, during chemotherapy may be at incr

Updated on:December 23,2023 24

Scientists uncover novel DNA repair mechanism for key cancer target

byThe Francis Crick InstituteGraphical Abstract. Credit:Molecular Cell(2022). DOI: 10.1016/j.molcel.2022.11.008Scientists at the Francis Crick Institute, in collaboration with Artios

Updated on: December 27,2023 9

Scientists uncover novel DNA repair mechanism for key cancer target

byThe Francis Crick InstituteGraphical Abstract. Credit:Molecular Cell(2022). DOI: 10.1016/j.molcel.2022.11.008Scientists at the Francis Crick Institute, in collaboration with Artios

Updated on:December 27,2023 9

Researchers find the key to genome-modifying drugs' sensitivity in malignant blood diseases

by Josep Carreras Leukaemia Research InstituteImpact of azacitidine on global DNA methylation patterns and definition of EPIAZA signature in patients with MDS. (A) Study design and workflow. (B,

Updated on: March 20,2024 11

Researchers find the key to genome-modifying drugs' sensitivity in malignant blood diseases

by Josep Carreras Leukaemia Research InstituteImpact of azacitidine on global DNA methylation patterns and definition of EPIAZA signature in patients with MDS. (A) Study design and workflow. (B,

Updated on:March 20,2024 11

Algorithm offers new way to spot patients likely to respond to immunotherapy

byInstitute of Cancer ResearchOverview of immune selection calculation using SOPRANO. a, Estimates can be performed at the cohort or at the single individual level. b, In each case, it is possib

Updated on: January 04,2024 9

Algorithm offers new way to spot patients likely to respond to immunotherapy

byInstitute of Cancer ResearchOverview of immune selection calculation using SOPRANO. a, Estimates can be performed at the cohort or at the single individual level. b, In each case, it is possib

Updated on:January 04,2024 9

Study opens door to targeted treatments for oesophageal cancer

byCancer Research UK| News5 September 2016Scientists have discovered thatoesophageal cancercan be classified into three different subtypes, paving the way for testing targeted

Updated on: December 19,2023 26

Study opens door to targeted treatments for oesophageal cancer

byCancer Research UK| News5 September 2016Scientists have discovered thatoesophageal cancercan be classified into three different subtypes, paving the way for testing targeted

Updated on:December 19,2023 26

Unique gene signature could help predict response to chemotherapy

byThe Francis Crick InstituteIn vitro anticancer drug screen. a Volcano plots showing differences in IC50 values between RAS high and low CCLE cell lines. Drugs with enriched target annotations

Updated on: December 20,2023 10

Unique gene signature could help predict response to chemotherapy

byThe Francis Crick InstituteIn vitro anticancer drug screen. a Volcano plots showing differences in IC50 values between RAS high and low CCLE cell lines. Drugs with enriched target annotations

Updated on:December 20,2023 10

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem,CU Anschutz Medical CampusRobert C. Doebele, MD, PhD. Credit: CU Anschutz Medical CampusPooled analysis of three phase 1 and 2 clinical trials published online ahead of print in

Updated on: December 22,2023 10

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem,CU Anschutz Medical CampusRobert C. Doebele, MD, PhD. Credit: CU Anschutz Medical CampusPooled analysis of three phase 1 and 2 clinical trials published online ahead of print in

Updated on:December 22,2023 10